Dan Williams discusses gene silencing in this important piece for Drug Target ReviewDr Dan WilliamsApr 151 min readGene silencing: a step forward for rare disease therapy - Drug Target Review
Drug Target Review features an insightful article by Dan Williams that explores the extraordinary achievements of AI in drug design
Technology Networks features a major interview with Dr Uwe Meya, SynaptixBio’s CMO, in which the issues around organising, funding, and conducting clinical trials for rare diseases are discussed.
Dan Williams contributes to a major article for Inside Precision Medicine, in which several US families with a child living with H-ABC discuss their journey to a diagnosis
Comments